Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 31, 2023

SELL
$0.47 - $17.22 $1,388 - $50,885
-2,955 Reduced 7.25%
37,787 $20,000
Q3 2022

Nov 14, 2022

BUY
$0.74 - $15.01 $2,186 - $44,354
2,955 Added 7.82%
40,742 $29,000
Q4 2021

Jan 21, 2022

SELL
$4.45 - $8.09 $21,119 - $38,395
-4,746 Reduced 11.16%
37,787 $179,000
Q3 2021

Oct 21, 2021

SELL
$6.94 - $8.85 $48 - $61
-7 Reduced 0.02%
42,533 $333,000
Q1 2021

May 11, 2021

BUY
$8.78 - $12.8 $373,501 - $544,512
42,540 New
42,540 $481,000

About CURIS INC


  • Ticker CRIS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 91,814,704
  • Market Cap $393M
  • Description
  • Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...
More about CRIS
Track This Portfolio

Track Kestra Private Wealth Services, LLC Portfolio

Follow Kestra Private Wealth Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Private Wealth Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Private Wealth Services, LLC with notifications on news.